drugset / Trial / NCT04144153

Opioid Free Anesthesia and Bariatric Surgery

NCT04144153 ↗

Phase 4 Completed 58 enrolled Northwell Health
RandomizedParallel-groupDouble-blindOther

Summary

The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.

Timeline

Start
2021-08-09
Primary completion
2023-09-01
Completion
2023-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — —
Subject Ketamine Small molecule — —
Subject Propofol Small molecule — —

Indications

No indication recorded.